Loading
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 06 Aug 2026 for Attovia Therapeutics, Inc.. Read the official filing
Filing timeline
BuySaleFrazier Life Sciences XI, L.P.
Insider track record
Disclosed buys
1
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Frazier Life Sciences XI, L.P.: trading record in brief
This profile gathers the share dealings of Frazier Life Sciences XI, L.P. in Attovia Therapeutics, Inc. We count 5 filings, every one of them for a trade on 6 August 2026.
On the market, this insider has only ever bought: 1 purchase, €8.6M in total. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.
The newest entry dates from 6 August 2026: a transaction, in Attovia Therapeutics, Inc. The most recent open-market purchase was published on 6 August 2026, 73 days ago. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Frazier Life Sciences XI, L.P.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations5 total
1,749,192 sharesCommon StockSEC:0001231919-26-000838:0
1,590,175 sharesCommon StockSEC:0001231919-26-000838:1
1,189,940 sharesCommon StockSEC:0001231919-26-000838:2
961,322 sharesCommon StockSEC:0001231919-26-000838:3
588,235 shares@ US$17.00Common StockSEC:0001231919-26-000838:4
Canonical exit: 4 Nov 2026 (T+90)
5 of 5 declarations
